Guangzhou Regenex Pharmaceuticals

Guangzhou Regenex Pharmaceuticals is a biotechnology company focused on developing innovative therapies for aging-related diseases and metabolic disorders. The company leverages its proprietary rejuvenation and regeneration platform to target NAD+ metabolism and sirtuin pathways. Their primary research focuses on conditions such as sarcopenia, chronic kidney disease, and metabolic dysfunction-associated steatohepatitis (MASH). By developing small molecule modulators and protein-based therapies, Regenex aims to restore cellular function and promote tissue repair in elderly populations. The company is headquartered in Guangzhou, China, and maintains active research collaborations to advance its early-stage pipeline.